Welcome to LookChem.com Sign In|Join Free
  • or
1H-1,2,4-Triazole-3-carboxylic acid, also known as 1,2,4-Triazole-3-carboxylic Acid, is an organic compound with the molecular formula C4H4N3O2. It is a significant metabolite derived from the antiviral agent Ribavirin (R414475), which is widely used in the treatment of various viral infections.

4928-87-4

Post Buying Request

4928-87-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4928-87-4 Usage

Uses

Used in Pharmaceutical Industry:
1H-1,2,4-Triazole-3-carboxylic acid is used as an intermediate in the synthesis of antiviral drugs, specifically for the production of Ribavirin (R414475). As a major metabolite of Ribavirin, it plays a crucial role in the drug's antiviral activity against infections such as hepatitis C, respiratory syncytial virus (RSV), and influenza.
Used in Antiviral Research:
1H-1,2,4-Triazole-3-carboxylic acid is utilized in the research and development of new antiviral agents. Its structural properties and metabolic profile make it a valuable compound for studying the mechanisms of action and potential improvements in antiviral drug design.
Used in Quality Control and Impurity Profiling:
In the pharmaceutical quality control process, 1H-1,2,4-Triazole-3-carboxylic acid (Ribavirin EP Impurity C) is used as a reference material for the identification and quantification of impurities in Ribavirin drug products. This helps ensure the safety, efficacy, and quality of the final drug product by monitoring and controlling impurities during manufacturing and formulation processes.

Check Digit Verification of cas no

The CAS Registry Mumber 4928-87-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,9,2 and 8 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 4928-87:
(6*4)+(5*9)+(4*2)+(3*8)+(2*8)+(1*7)=124
124 % 10 = 4
So 4928-87-4 is a valid CAS Registry Number.
InChI:InChI=1/C3H3N3O2/c7-3(8)2-4-1-5-6-2/h1H,(H,7,8)(H,4,5,6)/p-1

4928-87-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (658472)  1,2,4-Triazole-3-carboxylicacid  97%

  • 4928-87-4

  • 658472-1G

  • 424.71CNY

  • Detail
  • Aldrich

  • (658472)  1,2,4-Triazole-3-carboxylicacid  97%

  • 4928-87-4

  • 658472-10G

  • 2,098.98CNY

  • Detail

4928-87-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-[1,2,4]Triazole-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1,2,4-Triazole-3-Carboxylic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4928-87-4 SDS

4928-87-4Synthetic route

5-amino-1H-[1,2,4]triazole-3-carboxylic acid
3641-13-2

5-amino-1H-[1,2,4]triazole-3-carboxylic acid

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With hypophosphorous acid; sodium nitrite In isopropylalcohol; water at 5 - 50℃; for 1.41667h;95.6%
With hydrogenchloride; hypophosphorous acid; sodium nitrite In isopropylalcohol; water at 5 - 50℃; for 1.41667h;89.4%
Stage #1: 5-amino-1H-[1,2,4]triazole-3-carboxylic acid With sodium nitrite Sandmeyer Reaction;
Stage #2: With methanol Sandmeyer Reaction;
65%
Stage #1: 5-amino-1H-[1,2,4]triazole-3-carboxylic acid With hydrogenchloride; sodium nitrite Diazotization;
Stage #2: In methanol Hydrolysis; Heating;
45%
[1,2,4]triazolo[4,3-a]pyridine
274-80-6

[1,2,4]triazolo[4,3-a]pyridine

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With potassium permanganate
1--1.2.4-triazole-carboxylic acid-(3)

1--1.2.4-triazole-carboxylic acid-(3)

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With alkaline permanganate
3-methyl-1.2.4-triazole

3-methyl-1.2.4-triazole

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With alkaline permanganate
4-phenyl-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide
387362-37-0

4-phenyl-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With hydrogenchloride; water for 5h; Reflux;
4-(4-methoxyphenyl)-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide
1260230-04-3

4-(4-methoxyphenyl)-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With hydrogenchloride; water for 5h; Reflux;
4-(4-bromophenyl)-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide
1260230-06-5

4-(4-bromophenyl)-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With hydrogenchloride; water for 5h; Reflux;
4-cyclohexyl-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide
1260230-07-6

4-cyclohexyl-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With hydrogenchloride; water for 5h; Reflux;
4-butyl-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide
1260230-09-8

4-butyl-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With hydrogenchloride; water for 5h; Reflux;
4-ethyl-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide
1260230-10-1

4-ethyl-1-(1,2,4-triazol-3-yl-carbonyl)-thiosemicarbazide

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
With hydrogenchloride; water for 5h; Reflux;
1H-1,2,4-triazole-3,5-dicarboxylic acid
34550-41-9

1H-1,2,4-triazole-3,5-dicarboxylic acid

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

Conditions
ConditionsYield
Acidic conditions;
methanol
67-56-1

methanol

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

methyl 1H-1,2,4-triazole-3-carboxylate
4928-88-5

methyl 1H-1,2,4-triazole-3-carboxylate

Conditions
ConditionsYield
With thionyl chloride at 0 - 65℃; for 3h;97%
With thionyl chloride at 10 - 20℃;80%
With hydrogenchloride
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

4-(trifluoromethoxy)benzyl amine
93919-56-3

4-(trifluoromethoxy)benzyl amine

N-(4-(trifluoromethoxy)benzyl)-1H-1,2,4-triazole-3-carboxamide

N-(4-(trifluoromethoxy)benzyl)-1H-1,2,4-triazole-3-carboxamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 24h; Inert atmosphere;90%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

4-amino-o-xylene
95-64-7

4-amino-o-xylene

N-(3,4-dimethylphenyl)-1H-1,2,4-triazole-3-carboxamide

N-(3,4-dimethylphenyl)-1H-1,2,4-triazole-3-carboxamide

Conditions
ConditionsYield
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere;83%
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 20℃;75%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

N-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-1H-1,2,4-triazole-3-carboxamide

N-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)-1H-1,2,4-triazole-3-carboxamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; bromo-tris(1-pyrrolidinyl)phosphonium hexafluorophosphate In N,N-dimethyl-formamide at 25℃; for 2h; Cooling with ice;80%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-hydroxycyclobutanecarboxamidine
1361189-49-2

1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-hydroxycyclobutanecarboxamidine

5-(4-{1-[5-(1H-[1,2,4]triazol-3-yl)-[1,2,4]oxadiazol-3-yl]cyclobutyl}phenyl)pyrimidin-2-ylamine
1361187-29-2

5-(4-{1-[5-(1H-[1,2,4]triazol-3-yl)-[1,2,4]oxadiazol-3-yl]cyclobutyl}phenyl)pyrimidin-2-ylamine

Conditions
ConditionsYield
Stage #1: 1,2,4-triazole-3-carboxylic acid With 1,1'-carbonyldiimidazole In 1-methyl-pyrrolidin-2-one at 50℃; for 0.333333h; Inert atmosphere;
Stage #2: 1-[4-(2-aminopyrimidin-5-yl)phenyl]-N-hydroxycyclobutanecarboxamidine In 1-methyl-pyrrolidin-2-one at 100℃; for 4h; Inert atmosphere;
78%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

C12H17N3O5*C2HF3O2

C12H17N3O5*C2HF3O2

N-(3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-ylamino)-3-oxopropyl)-1H-1,2,4-triazole-3-carboxamide

N-(3-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-ylamino)-3-oxopropyl)-1H-1,2,4-triazole-3-carboxamide

Conditions
ConditionsYield
Stage #1: C12H17N3O5*C2HF3O2 With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0℃; for 0.166667h;
Stage #2: 1,2,4-triazole-3-carboxylic acid With bromo-tris(1-pyrrolidinyl)phosphonium hexafluorophosphate In N,N-dimethyl-formamide at 0 - 25℃; for 1h;
75%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1-(piperidin-3-yl)-1H-imidazo[4,5-c]quinolin-2(3H)-one

3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1-(piperidin-3-yl)-1H-imidazo[4,5-c]quinolin-2(3H)-one

1-(1-(1H-1,2,4-triazole-3-carbonyl)piperidin-3-yl)-3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-2(3H)-one

1-(1-(1H-1,2,4-triazole-3-carbonyl)piperidin-3-yl)-3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-2(3H)-one

Conditions
ConditionsYield
Stage #1: 1,2,4-triazole-3-carboxylic acid; 3-methyl-8-(6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-1-(piperidin-3-yl)-1H-imidazo[4,5-c]quinolin-2(3H)-one With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 4h;
Stage #2: With triethylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃;
73%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

2-chloro-1-(2,4-dichlorophenyl)ethanone
51336-94-8

2-chloro-1-(2,4-dichlorophenyl)ethanone

1-[2-(2,4-difluoro-phenyl)-2-oxo-ethyl]-1H-[1,2,4]triazole-3-carboxylic acid
913237-92-0

1-[2-(2,4-difluoro-phenyl)-2-oxo-ethyl]-1H-[1,2,4]triazole-3-carboxylic acid

Conditions
ConditionsYield
With triethylamine72%
2-chloro-1-(2-fluoro-4-methyl-phenyl)-ethanone
913237-84-0

2-chloro-1-(2-fluoro-4-methyl-phenyl)-ethanone

1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

1-[2-(2-fluoro-4-methyl-phenyl)-2-oxo-ethyl]-1H-[1,2,4]triazole-3-carboxylic acid
913237-93-1

1-[2-(2-fluoro-4-methyl-phenyl)-2-oxo-ethyl]-1H-[1,2,4]triazole-3-carboxylic acid

Conditions
ConditionsYield
With triethylamine69%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

2-bromo-1-(3,4-dichlorophenyl)ethanone
2632-10-2

2-bromo-1-(3,4-dichlorophenyl)ethanone

1-[2-(3,4-dichloro-phenyl)-2-oxo-ethyl]-1H-[1,2,4]triazole-3-carboxylic acid
913237-88-4

1-[2-(3,4-dichloro-phenyl)-2-oxo-ethyl]-1H-[1,2,4]triazole-3-carboxylic acid

Conditions
ConditionsYield
With triethylamine68%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

chloroanhydride of 1H-1,2,4-triazole-3-carboxylic acid hydrochloride

chloroanhydride of 1H-1,2,4-triazole-3-carboxylic acid hydrochloride

Conditions
ConditionsYield
With thionyl chloride for 4h; Reflux;68%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

N-(4-phenyl)benzylamine
712-76-5

N-(4-phenyl)benzylamine

N-[(1,1'-biphenyl)-4-ylmethyl]-1H-1,2,4-triazole-3-carboxamide

N-[(1,1'-biphenyl)-4-ylmethyl]-1H-1,2,4-triazole-3-carboxamide

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; 6-chloro-1-hydroxybenzotriazole In dichloromethane; N,N-dimethyl-formamide at 20℃; for 12h; Inert atmosphere;68%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

ethanol
64-17-5

ethanol

1H-1,2,4-triazole-3-carbocyclic acid ethyl ester hydrochloride

1H-1,2,4-triazole-3-carbocyclic acid ethyl ester hydrochloride

Conditions
ConditionsYield
Stage #1: 1,2,4-triazole-3-carboxylic acid; ethanol With thionyl chloride at 5 - 70℃; for 4h;
Stage #2: With hydrogenchloride
63.7%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

2-Bromo-4'-methoxyacetophenone
2632-13-5

2-Bromo-4'-methoxyacetophenone

1-[2-(4-methoxy-phenyl)-2-oxo-ethyl]-1H-[1,2,4]triazole-3-carboxylic acid

1-[2-(4-methoxy-phenyl)-2-oxo-ethyl]-1H-[1,2,4]triazole-3-carboxylic acid

Conditions
ConditionsYield
With triethylamine63%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

lead(II) nitrate

lead(II) nitrate

potassium iodide
7681-11-0

potassium iodide

catena-(1H-1,2,4-triazole-3-carboxyliate)(μ2-iodo)lead(II)
1429689-06-4

catena-(1H-1,2,4-triazole-3-carboxyliate)(μ2-iodo)lead(II)

Conditions
ConditionsYield
In water at 60℃; for 240h;63%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

C33H27N5O

C33H27N5O

1-[4-(8-(1H-1,2,4-triazole-3-carbonyl)-8-azabicyclo-[3.2.1]-oct-3-en-3-yl)phenyl]-3-methyl-8-(quinolin-3-yl)-1H-imidazo-[4,5-c]-quinolin-2-(3H)-one

1-[4-(8-(1H-1,2,4-triazole-3-carbonyl)-8-azabicyclo-[3.2.1]-oct-3-en-3-yl)phenyl]-3-methyl-8-(quinolin-3-yl)-1H-imidazo-[4,5-c]-quinolin-2-(3H)-one

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;60%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

(R)-1-(4-methoxyphenyl)ethylamine
6298-96-0, 22038-86-4, 35600-82-9, 41851-59-6

(R)-1-(4-methoxyphenyl)ethylamine

(R)-N-(1-(4-methoxyphenyl)ethyl)-1H-1,2,4-triazole-3-carboxamide

(R)-N-(1-(4-methoxyphenyl)ethyl)-1H-1,2,4-triazole-3-carboxamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 24h; Inert atmosphere;58%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

water
7732-18-5

water

lead(II) chloride

lead(II) chloride

[Pb(3-carboxylic acid-4H-1,2,4-triazole(-H))(μ2-Cl)(H2O)](n)

[Pb(3-carboxylic acid-4H-1,2,4-triazole(-H))(μ2-Cl)(H2O)](n)

Conditions
ConditionsYield
In water High Pressure; mixt. of PbCl2, org. ligand and H2O placed in Teflon-lined steel vessel and heated to 140 °C for 3 d; washing (water, diethyl ether), elem. anal.;57%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

lead(II) nitrate

lead(II) nitrate

potassium chloride

potassium chloride

[Pb(3-carboxylic acid-4H-1,2,4-triazole(-H))(μ2-Cl)(H2O)](n)

[Pb(3-carboxylic acid-4H-1,2,4-triazole(-H))(μ2-Cl)(H2O)](n)

Conditions
ConditionsYield
at 60℃; for 168h;57%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

1-(2-tert-butylphenyl)piperazine dihydrochloride

1-(2-tert-butylphenyl)piperazine dihydrochloride

1-(2-tert-Butylphenyl)-4-(1H-1,2,4-triazol-3-ylcarbonyl)piperazine
1252656-17-9

1-(2-tert-Butylphenyl)-4-(1H-1,2,4-triazol-3-ylcarbonyl)piperazine

Conditions
ConditionsYield
Stage #1: 1,2,4-triazole-3-carboxylic acid; 1-(2-tert-butylphenyl)piperazine dihydrochloride With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 20℃; for 16h;
Stage #2: With sodium hydrogencarbonate In ethyl acetate
56%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

C31H27N5O

C31H27N5O

1-(4-(1-(4H-1,2,4-triazol-3-carbonyl)piperidin-4-yl)phenyl)-3-methyl-8-(quinolin-3-yl)-1H-imidazo[4,5-c]quinolin-2-(3H)-one

1-(4-(1-(4H-1,2,4-triazol-3-carbonyl)piperidin-4-yl)phenyl)-3-methyl-8-(quinolin-3-yl)-1H-imidazo[4,5-c]quinolin-2-(3H)-one

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;55.6%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

C31H27N5O

C31H27N5O

1-(4-(1-(1H-1,2,4-triazol-3-carbonyl)-1,2,3,6-tetrahydropyridin-4-yl)phenyl)-3-methyl-8-(quinolin-3-yl)-1H-imidazo[4,5-c]quinolin-2-(3H)-one

1-(4-(1-(1H-1,2,4-triazol-3-carbonyl)-1,2,3,6-tetrahydropyridin-4-yl)phenyl)-3-methyl-8-(quinolin-3-yl)-1H-imidazo[4,5-c]quinolin-2-(3H)-one

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;55.5%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

benzylamine
100-46-9

benzylamine

1,2,4-triazole-3-benzamide

1,2,4-triazole-3-benzamide

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; triethylamine In acetonitrile at 20℃; for 2h; Acylation;55%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

lead(II) nitrate

lead(II) nitrate

[Pb(1H-1,2,4-triazole-3-carboxylate)(μ2-Br)(H2O)]n
1338359-40-2

[Pb(1H-1,2,4-triazole-3-carboxylate)(μ2-Br)(H2O)]n

Conditions
ConditionsYield
With potassium bromide at 60℃; for 72h;54%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

lead(II) nitrate

lead(II) nitrate

potassium bromide
7558-02-3

potassium bromide

[Pb(1H-1,2,4-triazole-3-carboxylate)(μ2-Br)(H2O)]n
1338359-40-2

[Pb(1H-1,2,4-triazole-3-carboxylate)(μ2-Br)(H2O)]n

Conditions
ConditionsYield
at 60℃; for 168h;54%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

manganese(II) chloride tetrahydrate

manganese(II) chloride tetrahydrate

water
7732-18-5

water

[Mn(1H-1,2,4-triazole-3-carboxylate)2(H2O)2]

[Mn(1H-1,2,4-triazole-3-carboxylate)2(H2O)2]

Conditions
ConditionsYield
With 1,3-bis(1,2,4-triazol-1-yl)propane at 20℃; for 6h;52.2%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

(3aR,5R,6aS)-5-(2-(trifluoromethyl)phenyl)octahydrocyclopenta[c]pyrrole hydrochloride

(3aR,5R,6aS)-5-(2-(trifluoromethyl)phenyl)octahydrocyclopenta[c]pyrrole hydrochloride

(1H-1,2,4-triazol-3-yl)((3aR,5R,6aS)-5-(2-(trifluoromethyl)phenyl)hexahydrocyclopenta[c]pyrrole-2(1H)-yl)methanone

(1H-1,2,4-triazol-3-yl)((3aR,5R,6aS)-5-(2-(trifluoromethyl)phenyl)hexahydrocyclopenta[c]pyrrole-2(1H)-yl)methanone

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine In N,N-dimethyl-formamide at 20℃;52%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

(3aR,6aS)-5-(2-(trifluoromethyl)phenyl)octahydrocyclopenta[c]pyrrole hydrochloride

(3aR,6aS)-5-(2-(trifluoromethyl)phenyl)octahydrocyclopenta[c]pyrrole hydrochloride

3-{[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]octahydrocyclopenta[c]pyrrol-2-yl]carbonyl}-1H-1,2,4-triazole

3-{[(3aR,6aS)-5-[2-(trifluoromethyl)phenyl]octahydrocyclopenta[c]pyrrol-2-yl]carbonyl}-1H-1,2,4-triazole

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine In N,N-dimethyl-formamide at 20℃;52%
1,2,4-triazole-3-carboxylic acid
4928-87-4

1,2,4-triazole-3-carboxylic acid

manganese(II) chloride tetrahydrate

manganese(II) chloride tetrahydrate

water
7732-18-5

water

[Mn(1H-1,2,4-triazole-3-carboxylate)2(H2O)2]

[Mn(1H-1,2,4-triazole-3-carboxylate)2(H2O)2]

Conditions
ConditionsYield
With potassium hydroxide at 60℃; for 240h;51.3%

4928-87-4Relevant academic research and scientific papers

Self-assembly of novel manganese (II) compounds based on bifunctional-group ligands: Synthesis, structures, and magnetic properties

Yan, Juan-zhi,Lu, Li-ping,Zhu, Miao-li,Feng, Si-si

, p. 351 - 359 (2018)

Four manganese (II) compounds are obtained by the reaction of manganese salts, triazole-derivatives and auxiliary reagents in aqueous solution or mix-solvents by routine or hydrothermal reactions. X-ray crystal structure analyses reveal that a neutral 0D compound [Mn(Hmctrz)2(H2O)2] (1) (H2mctrz = 1H-1,2,4-triazole-3-carboxylic acid) displays a centro-symmetric mononuclear octahedral entity with two Hmctrz? anions and two water molecules; two neutral 2D clusters [Mn(Hdctrz)(H2O)2]n (2) (H3dctrz = 1H-1,2,4-triazole-3,5-dicarboxylic acid) and [Mn2(pbtrz)(btca)]n·4nH2O (3) (pbtrz = 1,3-bis(1,2,4-triazol-1-yl)-propane&H4btca = benzene-1,2,4,5-tetracarboxylic acid) possess layer structures with Hdctrz2? linkers (2) and Mn(II)-pbtrz-Mn(II) building blocks periodically extended by μ-btca4? connectors (3); [Mn(pbtrz)]n·nOAc·nOH (4) shows a 3D diamond-shaped cationic framework with the anion void volume of 49.2%. Nitrogenous bases are used as the auxiliary ligand in compound 3 and the temple ligand in compounds 1, 2, and 4. Compounds 1–4 show antiferromagnetic coupling that has been fitted by different models with the molecular field approximate with D = ? 0.129(1) cm?1 for 1, J = ? 0.354(4) cm?1 for 2 and J = ? 0.696(6) cm?1 for 3, respectively. The magnetic differences can be related to different superexchange interactions transmitted by the crystal lattice and/or the zero field splitting (ZFS) of the 6A1g single-ion states of 1 and the syn-anti-COO? of 2 as well as the mixed magnetic bridges of μ1-O and μ-pbtrz-μ-COO? of 3.

Triazoles as T2-Exchange Magnetic Resonance Imaging Contrast Agents for the Detection of Nitrilase Activity

Zhang, Jia,Han, Zheng,Lu, Jiaqi,Li, Yuguo,Liao, Xuhe,van Zijl, Peter C.,Yang, Xing,Liu, Guanshu

, p. 15013 - 15018 (2018)

We characterized the T2-exchange (T2ex) magnetic resonance imaging (MRI) contrast of azole protons that have large chemical shifts from the water proton resonance as a function of pH, temperature, and chemical modification. Our results showed that 1,2,4-triazoles could be tuned into excellent diamagnetic T2ex contrast agents, with an optimal exchange-based relaxivity r2ex of 0.10 s?1 mm?1 at physiological pH and B0=9.4 T. A fit of r2ex data to the Swift–Connick equation indicated that imino proton exchange of triazoles is dominated by a base-catalyzed process at higher pH values and an acid-catalyzed process at lower pH. The magnitude of r2ex was also found to be heavily dependent on chemical modifications, that is, enhanced by electron-donating groups, such as amines and methyls, or by intramolecular hydrogen bonding between the imino proton and the carboxyl, and weakened by electron-withdrawing groups like bromo, cyano, and nitro. In light of these findings, we applied T2ex MRI to assess the activity of nitrilase, an enzyme catalyzing the hydrolysis of 1,2,4-triazole-3-carbonitrile to 1,2,4-triazole-3-carboxylic acid, resulting in the enhancement of R2ex. Our findings suggest that 1,2,4-triazoles have potential to provide sensitive and tunable diagnostic probes for MRI.

Preparation method of 1-methyl-1H-1,2,4-triazole-3-methyl formate

-

Paragraph 0021-0036, (2021/09/01)

The invention discloses a preparation method of 1-methyl-1H-1,2,4-triazole-3-methyl formate, belonging to the technical field of organic synthesis. The method comprises the following steps: with aminoguanidine bicarbonate and oxalic acid as raw materials, adding inorganic strong base for cyclization to obtain 3-aminotriazole-5-carboxylic acid; then subjecting 3-aminotriazole-5-carboxylic acid to reacting with sodium nitrite under an acidic condition to obtain diazonium salt; then subjecting diazonium salt to reacting with hypophosphorous acid to obtain 1,2,4-triazole-3-carboxylic acid; and then subjecting 1,2,4-triazole-3-carboxylic acid to reacting with a methylation reagent to obtain 1-methyl-1H-1,2,4-triazole-3-methyl formate. The method is simple to operate, raw materials are easy to obtain, and economic applicability of the method is high.

Synthesis method of 1, 2, 4-triazole-3-formic acid

-

Paragraph 0030; 0032; 0034; 0036; 0038; 0040; 0042; 0044, (2020/08/09)

The invention provides a synthesis method of 1, 2, 4-triazole-3-formic acid, which comprises the following steps: reacting oxalylhydrazine and a formamidine salt in an organic solvent to obtain 1, 2,4-triazole-3-formyl-(N-phenyl) amine; then heating and hydrolyzing in an alkaline solution in the presence of a catalyst, and adjusting the pH value by using an acid to obtain 1, 2, 4-triazole-3-formic acid; the method has the advantages of accessible raw materials, mild reaction conditions, simple post-treatment and higher yield, avoids the explosion risk and environment-polluting stink substances in the traditional technique, obviously reduces the three wastes, and has industrialization prospects.

Chemoenzymatic method of 1,2,4-triazole nucleoside synthesis: Possibilities and limitations

Konstantinova,Chudinov,Fateev,Matveev,Zhurilo,Shvets,Miroshnikov

, p. 53 - 71 (2013/04/10)

Possibilities and limitations of chemoenzymatic synthesis of novel structural analogues of an antiviral preparation of Ribavirin (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) were established. A synthesis of various amides of 1H-1,2,4-triazole-3-carboxylic acid and its 5-substituted analogues - potential substrates of purine nucleoside phosphorylase - has been described. Comparative efficiency of preparation methods of these amides, as well as the methods of introduction of functional groups to the C5 position of heterocyclic system, were investigated. Novel analogues of Ribavirin containing various substitutes in the carboxamide group were synthesized. A biotechnological method was developed for the preparation of 1-β-D-ribofuranozyl-1,2,4-triazole-3-carbonitryl, an intermediate in the synthesis of Viramidine, the modern analogue of Ribavirin.

Study of direction of cyclization of 1-azolil-4-aryl/alkyl- thiosemicarbazides

Siwek, Agata,Wujec, Monika,Dobosz, Maria,Wawrzycka-Gorczyca, Irena

experimental part, p. 521 - 532 (2011/08/03)

On a four series of 1-azolil-4-aryl/alkyl-thiosemicabazides, a study on the influence of azole moiety on the capability for intramolecular cyclization and its direction was carried out. It was found that for 4-aryl/alkyl- thiosemicabazides with triazole, imidazole, or pyrrole moiety at N-1 nitrogen atom possible products were only s-triazoles, both in alkaline and acidic medium. Successful dehydrocyclization of 1-azolil-4-aryl/alkyl- thiosemicarbazides leading to a thiadiazole has been documented only for a series of 1-(4-methyl-1,2,3-thiadiazol-5-yl-carbonyl)-4-aryl/alkyl- thiosemicarbazides. It can be speculative that the determination of pK a value of oxygen atom of 1-azolil-4-aryl/alkyl-thiosemicarbazide can be a very valuable parameter in the prediction of the possibility of dehydrocyclization to form thiadiazole.

NOVEL PROCESSES FOR THE PREPARATION OF SUBSTITUTED PROPENONE DERIVATIVES

-

Page 22, (2010/11/30)

The present invention provides industrial and commercial processes for the preparation of 2-acyl-5-benzylfuran derivatives, 1,2,4-triazole-3-carboxylic acid ester derivatives and propenone derivatives having anti-HIV activities and usuful crystals thereof. wherein R1, R2 and R4 each is independently hydrogen or the like; A is CR6 or N; R6 is hydrogen or the like; Q is a protecting group; and L is a leaving group.

Towards the engineering of an orthogonal protein kinase/nucleotide triphosphate pair

Ulrich, Scott M,Buzko, Oleksandr,Shah, Kavita,Shokat, Kevan M

, p. 9495 - 9502 (2007/10/03)

Remolding protein/ligand interfaces has led to the development of new tools for the study of biological systems. Such methods allow one to engineer proteins with specificity for designed biological probes such as inhibitors, substrates or small molecule dimerizers. Previous work in our laboratory has resulted in engineered protein kinases with specificity for ATP analogs which are otherwise orthogonal ligands for wild type kinases. Kinase reactions of analog-sensitive mutant kinases in cell lysates using γ32P labeled ATP analogs allow identification of the direct substrates of the sensitized kinase. As an extension of this methodology, we have designed and evaluated an ATP analog, N4 (benzyl) ribavirin triphosphate, which may be a suitable phosphodonor for a kinase that does not utilize ATP. Such a modification is likely to be necessary for in vivo kinase substrate labeling experiments where competitive phosphodonors are present in high concentrations. (C) 2000 Elsevier Science Ltd.

ENZYMATIC PREPARATIONS AND REGIOCHEMICAL PROPERTIES OF SOME NEW ADP-RIBOSYLATED 1,2,4-TRIAZOLES

Tono-oka, Shuichi,Azuma, Ichiro

, p. 297 - 300 (2007/10/02)

NAD nucleosidase-catalysed trans-ADP-ribosylation has been investigated for some 1,2,4-triazole bases.The unsubstituted base 1 provided N4-ribosylated triazoles (14 and 9), whereas 3-substituted (amino, chloro, mercapto, and carbamoyl)triazoles 2-4 and 6 underwent a regiospecific N1-ribosylation to produce the corresponding triazole adenine dinucleotides 10-13 in a good or moderate yield.Dinucleotide structures and the site of ribosylation were verified by 1H and 15N NMR spectrometries.The 3-carbamoyltriazole dinucleotide 13 can be a useful intermediate on the road to the antiviral agent, ribavirin, 18.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4928-87-4